2019

• Dopamine and addiction: what have we learned from 40 years of research. Solinas M, Belujon P, Fernagut PO, Jaber M, Thiriet N.J Neural Transm (Vienna). 2019 Apr;126(4):481-516. doi: 10.1007/s00702-018-1957-2. Epub 2018 Dec 19.

2018

• Impulse control disorders in Parkinson’s disease. Marques A, Durif F, Fernagut PO.J Neural Transm (Vienna). 2018 Aug;125(8):1299-1312. doi: 10.1007/s00702-018-1870-8. Epub 2018 Mar 7.

2017

• Impulse control disorders and levodopa-induced dyskinesias in Parkinson’s disease: an update. Voon V, Napier TC, Frank MJ, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M, Obeso J, Bezard E, Fernagut PO. Lancet Neurol. 2017 Mar;16(3):238-250. doi: 10.1016/S1474-4422(17)30004-2. Epub 2017 Feb 15. Review.
• Monoaminergic Modulation of Motor Cortex Function. Vitrac C, Benoit-Marand M. Front Neural Circuits. 2017 Oct 9;11:72. doi: 10.3389/fncir.2017.00072. eCollection 2017. Review.

2016

• Bezard E: Targeting alpha-synuclein: Therapeutic options. Mov Disord 2016; 31: 882-8
• Dehay B, Fernagut PO: Alpha-synuclein-based models of Parkinson’s disease. Rev Neurol (Paris) 2016
• Fernagut PO. Etiology and Progression of Parkinson’s Disease: Cross-Talk Between Environmental Factors and Genetic vulnerability. Handbook of Basal Ganglia Structure and Function. Eds Elsevier (in press 2016) (book chapter)

2015

• Bastide MF*, Meissner WG*, Picconi B*, Fasano S*, Fernagut PO*, Feyder M*, et al Pathophysiology of Ldopa-
  induced motor and non-motor complications in Parkinson’s disease. Prog Neurobiol 2015; 132:
  96-168. * co-first authors

2014

• Bassil F, Fernagut PO, Bezard E, Meissner WG: Insulin, IGF-1 and GLP-1 signaling in neurodegenerative
  disorders: targets for disease modification? Prog Neurobiol 2014; 118: 1-18
• Bezard E, Fernagut PO: Premotor parkinsonism models. Parkinsonism Relat Disord 2014; 20 Suppl 1: S17-9
• Fernagut PO, Dehay B, Maillard A, Bezard E, Perez P, Pavy-Le Traon A, Rascol O, Foubert-Samier A, Tison F, Meissner WG: Multiple system atrophy: a prototypical synucleinopathy for disease-modifying therapeutic strategies. Neurobiol Dis 2014; 67: 133-9

2013

• Jaber M, Benoit-Marand M, Prestoz L, Gaillard A. « Cell transplantation in the damaged adult brain. » Revue Neurologique. 2013;169(11):838-43). (review)
• Jaber M. « CLARITY or the invisible brain. » Mov. Dis. 2013;28(12):1639. (comment)

2012

• Saha B, Jaber M and Gaillard A. « Potentials of endogenous neural stem cells in brain repair. » Front Cell Neurosci. 2012;6:14.
• Prestoz L, Jaber M and Gaillard A. « Dopaminergic axon guidance: which makes what? » Front Cell Neurosci. 2012;6:32
• Jaber M and Gaillard A. « Cell transplantation: relevance in understanding brain development and prospects in brain repair ». Front Cell Neurosci. 2012;6:56
• Fernagut PO, Tison F: Animal models of multiple system atrophy. Neuroscience 2012; 211: 77-82

2011

• Gaillard A, Jaber M. Rewiring the brain with cell transplantation in Parkinson’s disease. Trends Neurosci. 2011 Mar;34(3):124-33.